Sunshine Biopharma (SBFMW) FCF Margin Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFMW) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 74.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -1,043.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -573.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 734.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 301.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -45,890.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 610.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 102,307.00 |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -655.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -655.00 |
| Dec 31, 2025 | 1,773.00 |
| Sep 30, 2025 | 1,440.00 |
| Jun 30, 2025 | 4,425.00 |
| Mar 31, 2025 | 2,395.00 |
| Dec 31, 2024 | -652.00 |
| Sep 30, 2024 | -1,437.00 |
| Jun 30, 2024 | 826.00 |
| Mar 31, 2024 | -527.00 |
| Dec 31, 2023 | 3,190.00 |
| Sep 30, 2023 | 83,830.00 |
| Jun 30, 2023 | 31,381.00 |
| Mar 31, 2023 | 102,560.00 |
| Dec 31, 2022 | 30,474.00 |
| Sep 30, 2022 | 34,651.00 |
| Jun 30, 2022 | 78,867.00 |
| Mar 31, 2022 | -32,109.00 |
| Dec 31, 2021 | 114,713.00 |
| Sep 30, 2021 | -48,491.00 |
| Jun 30, 2021 | -62,889.00 |